Annika Lindqvist1, Jaap Rip2, Joan van Kregten2, Pieter J Gaillard2, Margareta Hammarlund-Udenaes3. 1. Department of Pharmaceutical Biosciences, Translational PKPD Research Group, Associate member of SciLife Lab, Uppsala University, Box 591, Uppsala, SE-75124, Sweden. 2. to-BBB technologies BV, J. H. Oortweg 19, 2333 CH, Leiden, The Netherlands. 3. Department of Pharmaceutical Biosciences, Translational PKPD Research Group, Associate member of SciLife Lab, Uppsala University, Box 591, Uppsala, SE-75124, Sweden. mhu@farmbio.uu.se.
Abstract
PURPOSE: The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a targeted nanocarrier in vivo. METHODS: The evaluation was performed in rats using microdialysis, which enabled continuous sampling of the released drug in both the brain (striatum) and blood. Uptake in brain could thereby be studied in terms of therapeutically active, released drug. RESULTS: We found that encapsulation of the peptide DAMGO in fast-releasing polyethylene glycol (PEG)ylated liposomes, either with or without the specific brain targeting ligand glutathione (GSH), doubled the uptake of DAMGO into the rat brain. The increased brain delivery was observed only when the drug was encapsulated into the liposomes, thus excluding any effects of the liposomes themselves on the blood-brain barrier integrity as a possible mechanism. The addition of a GSH coating on the liposomes did not result in an additional increase in DAMGO concentrations in the brain, in contrast to earlier studies on GSH coating. This may be caused by differences in the characteristics of the encapsulated compounds and the composition of the liposome formulations. CONCLUSIONS: We were able to show that encapsulation into PEGylated liposomes of a peptide with limited brain delivery could double the drug uptake into the brain without using a specific brain targeting ligand.
PURPOSE: The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a targeted nanocarrier in vivo. METHODS: The evaluation was performed in rats using microdialysis, which enabled continuous sampling of the released drug in both the brain (striatum) and blood. Uptake in brain could thereby be studied in terms of therapeutically active, released drug. RESULTS: We found that encapsulation of the peptide DAMGO in fast-releasing polyethylene glycol (PEG)ylated liposomes, either with or without the specific brain targeting ligand glutathione (GSH), doubled the uptake of DAMGO into the rat brain. The increased brain delivery was observed only when the drug was encapsulated into the liposomes, thus excluding any effects of the liposomes themselves on the blood-brain barrier integrity as a possible mechanism. The addition of a GSH coating on the liposomes did not result in an additional increase in DAMGO concentrations in the brain, in contrast to earlier studies on GSH coating. This may be caused by differences in the characteristics of the encapsulated compounds and the composition of the liposome formulations. CONCLUSIONS: We were able to show that encapsulation into PEGylated liposomes of a peptide with limited brain delivery could double the drug uptake into the brain without using a specific brain targeting ligand.
Authors: B Sarkadi; M Müller; L Homolya; Z Holló; J Seprödi; U A Germann; M M Gottesman; E M Price; R C Boucher Journal: FASEB J Date: 1994-07 Impact factor: 5.191
Authors: Jaap Rip; Linda Chen; Robin Hartman; Angelique van den Heuvel; Arie Reijerkerk; Joan van Kregten; Burt van der Boom; Chantal Appeldoorn; Marco de Boer; David Maussang; Elizabeth C M de Lange; Pieter J Gaillard Journal: J Drug Target Date: 2014-02-14 Impact factor: 5.121
Authors: Guoyan G Xu; Olga Yu Zolotarskaya; Dwight A Williams; Yunyun Yuan; Dana E Selley; William L Dewey; Hamid I Akbarali; Hu Yang; Yan Zhang Journal: ACS Med Chem Lett Date: 2016-11-21 Impact factor: 4.345
Authors: Feilong Sun; Tessa C C Jaspers; Peter M van Hasselt; Wim E Hennink; Cornelus F van Nostrum Journal: Pharm Res Date: 2016-05-31 Impact factor: 4.200
Authors: Joy N Reginald-Opara; Darren Svirskis; Song Yee Paek; Mingtan Tang; Simon J O'Carroll; Justin M Dean; Lawrence W Chamley; Zimei Wu Journal: Mater Today Bio Date: 2022-02-05
Authors: Yana Zorkina; Olga Abramova; Valeriya Ushakova; Anna Morozova; Eugene Zubkov; Marat Valikhov; Pavel Melnikov; Alexander Majouga; Vladimir Chekhonin Journal: Molecules Date: 2020-11-13 Impact factor: 4.411